3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Prostatic Neoplasms
8
Carcinoma, Renal Cell
6
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Wilms Tumor
2
Squamous Cell Carcinoma of Head and Neck
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Neoplasms
2
Myeloproliferative Disorders
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Hairy Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombocytosis
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Cyclophosphamide
4
Specimen Handling
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
Granulocyte Colony-Stimulating Factor
3
Busulfan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
talazoparib
2
selpercatinib
2
palbociclib
2
ivosidenib
2
fludarabine
2
cabozantinib
2
Vemurafenib
2
Topotecan
2
Temozolomide
2
Sirolimus
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
LY3023414
2
Filgrastim
2
Bone Marrow Transplantation
2
trioctyl phosphine oxide
1
regorafenib
1
racotumomab
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Vorinostat
×
Genitourinary
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled